India, May 1 -- KTM recently brought back one of its most extreme production bikes for 2027, but buyers will need to act fast. The KTM 450 Rally Replica is being built in very small numbers and is aim... Read More
MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611025319 A) filed by Chitkara University, Rajpura, Punjab, on March 3, for 'handheld device for targeted tis... Read More
MUMBAI, India, May 1 -- Intellectual Property India has published a patent application (202611025247 A) filed by Mr. Simar Kapoor; and Mr. Satvik Kapoor, New Delhi, on March 3, for 'thermoforming anti... Read More
WASHINGTON, May 1 -- Sen. Jacky Rosen issued the following press release: Yesterday, during a Senate Armed Services Committee hearing, Senator Rosen called out Secretary of Defense Pete Hegseth over ... Read More
Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and E... Read More
Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and T... Read More
Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral nera... Read More
Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Do... Read More
Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib... Read More
Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined... Read More